Diclegis is a prescription medication used to treat nausea and vomiting of pregnancy, commonly known as morning sickness [1]. It is a combination of doxylamine succinate and pyridoxine hydrochloride [2].
What is Diclegis approved for?
Diclegis is approved by the U.S. Food and Drug Administration (FDA) for pregnant individuals experiencing nausea and vomiting [1]. It is indicated for women who have not improved after trying dietary changes or other non-prescription treatments [3].
How does Diclegis work?
Diclegis contains two active ingredients: doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a form of vitamin B6 [2]. Doxylamine succinate helps to reduce nausea and vomiting by blocking the action of histamine, a chemical in the body that can cause these symptoms. Pyridoxine hydrochloride is a vitamin that may also play a role in reducing nausea [4].
When does Diclegis patent expire?
Information on specific patent expiry dates for Diclegis is available through specialized drug patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can help determine when generic versions may become available [5].
What are the alternatives to Diclegis?
Before or in conjunction with Diclegis, some pregnant individuals may try lifestyle and dietary changes, such as eating smaller, more frequent meals, avoiding trigger foods, and getting adequate rest [3]. If these measures are insufficient, other antiemetic medications might be considered by a healthcare provider [1].
Are there generic versions of Diclegis?
The availability of generic versions of Diclegis depends on the expiry of its patents and any periods of market exclusivity. DrugPatentWatch.com provides detailed information on patent status and potential generic entry timelines [5].